1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. PALVELLA THERAPEUTICS INC.

Palvella Therapeutics Inc.

XNAS: PVLA

Download real time

27.28 -0.33 (-1.20%)

New 52W High in past week

35,978 XNAS Volume

XNAS 20 Mar, 2025 12:55 PM (EDT)

Watchlist

Portfolio

Share
11S
4W
3O
2T
306.1

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

-4

Price to Book

Negative Price to Book
-

Beta 1Year



Insider Trading disclosures for Palvella Therapeutics Inc.

The latest disclosure was made by Jeffrey Martini in Palvella Therapeutics Inc. where a trade of 5,373 Incentive Stock Option (right to buy) done was reported to US exchanges on Feb. 5, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jeffrey Martini Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 5,373 5,373 - - Incentive Stock Option (right to buy)
Jeffrey Martini Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 123,559 123,559 - - Non-Qualified Stock Option (right to buy)
Kathleen Goin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 5,373 5,373 - - Incentive Stock Option (right to buy)
Kathleen Goin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 123,559 123,559 - - Non-Qualified Stock Option (right to buy)
Wesley H. Kaupinen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 243,831 243,831 - - Non-Qualified Stock Option (right to buy)
Matthew Korenberg CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 123,559 123,559 - - Non-Qualified Stock Option (right to buy)
Matthew Korenberg CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 5,373 5,373 - - Incentive Stock Option (right to buy)
M. Jenkins George Director Purchase of securities on an exchange or from another person at price $ 12.93 per share. 18 Dec 2024 4,000 180,671 - 12.9 51,720 Common Stock
Tadd S. Wessel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 24,700 24,700 - - Stock Option (right to buy)
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 24,700 24,700 - - Stock Option (right to buy)
George M. Jenkins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 24,700 24,700 - - Stock Option (right to buy)
Jeffrey Martini Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 126,416 126,416 - - Stock Option (right to buy)
Kathleen Goin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 27,843 27,843 - - Stock Option (right to buy)
Wesley H. Kaupinen Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 417,806 417,806 - - Stock Option (right to buy)
Christopher Kiritsy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 24,700 24,700 - - Stock Option (right to buy)
Matthew Korenberg CFO, Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 167,100 167,100 - - Stock Option (right to buy)
Todd C. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 24,700 24,700 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters